Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-06, Stock:PFE, The news for the past five days is as follows:
2021-04-29: NEWS1: Eaton Vance Worldwide Health Sciences Fund's Top 4 1st-Quarter Trades.NEWS2: Covid Shots Come in Bulk. The World Needs Single Servings.NEWS3: Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving.NEWS4: Moderna ramps up investments to triple vaccine output, eyes boosters.NEWS5: Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters.NEWS6: NYC reopening timeline is a ‘disastrous issue’: Doctor.NEWS7: Doctor: Travel ban from India to the U.S. could be 'counterproductive'.NEWS8: Bristol-Myers (BMY) Misses on Q1 Earnings, Opdivo Sales Decline.NEWS9: Will Pfizer (PFE) Deliver a Beat This Earnings Season?.NEWS10: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS11: World to spend $157 billion on COVID-19 vaccines through 2025 -report.NEWS12: UPDATE 1-BioNTech expects vaccine trial results for babies by September.NEWS13: REFILE-BioNTech expects vaccine trial results for babies by September.
2021-04-30: NEWS1: Why Pfizer and BioNTech Shot Higher on Friday.NEWS2: Breakout Success: BioNTech Stock Pops On Covid Vaccine For Teens.NEWS3: UPDATE 1-Pfizer to start shipping coronavirus vaccine to Canada.NEWS4: UPDATE 3-Brazil pharma flags 'retaliation' risk over bill to drop vaccine patents.NEWS5: COVID SCIENCE-Vaccine protects COVID-19 survivors against variants; virus' spike protein damages blood vessels.NEWS6: 'Things are going to get much worse before they get better' in India: Expert.NEWS7: West Virginia Governor on offering incentives after state ‘hit a wall’ in vaccinations.NEWS8: The Eaton Vance Fund sells Novartis, Pfizer.NEWS9: Canada to begin getting doses of Pfizer-BioNTech vaccine from U.S. next week.NEWS10: 2 Doses Pfizer-BioNTech COVID-19 Vaccine Necessary To Generate Immune Response Against Variants, UK Study Show: Reuters.NEWS11: California has lowest COVID-19 case rate in the U.S.: RPT.NEWS12: Pfizer to export U.S.-made COVID-19 shots to Canada starting next week.NEWS13: BioNTech - Pfizer COVID-19 Shot Expected To Be Effective Against Double Mutants, Says BNTX CEO: CNBC.NEWS14: Turkey says it will receive 1 mln doses of BioNTech vaccines in May.NEWS15: Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs.NEWS16: UPDATE 1-Risk from virus variants remains after first Pfizer COVID-19 vaccine, UK study finds.NEWS17: UPDATE 2-In vaccine supply crunch, Mexico angles for 5 million doses from U.S..NEWS18: Risk from virus variants remains after first Pfizer COVID-19 vaccine, UK study finds.NEWS19: South Africa regulator says J&J shot can be given to pregnant women.NEWS20: Pfizer and BioNTech Ask EU for Covid-19 Vaccine Authorization in Adolescents.NEWS21: UPDATE 2-Erdogan says Turkey expects more COVID-19 vaccines soon.NEWS22: Pfizer to Export U.S.-Made Vaccine Doses, Report Says.NEWS23: BioNTech and Pfizer seek regulatory OK in Europe to extend vaccine authorization to 12- to 15-year-olds.NEWS24: UPDATE 1-Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU.NEWS25: AstraZeneca COVID-19 Vaccine Costs Hit Q1 Earnings; Cancer Meds, Emerging Markets Save The Day.NEWS26: 3 Healthcare Stocks That Could Be Millionaire-Makers.NEWS27: 2 Stocks to Buy with Dividends Yielding More Than 3%.NEWS28: Pfizer Submits EU Vaccine Authorization Request for Ages 12-15.NEWS29: AstraZeneca delivers $275m in sales from COVID vaccines.NEWS30: UPDATE 2-Brazil Senate votes to suspend patent protection on COVID-19 vaccines.
2021-05-03: NEWS1: AbbVie's Humira Still Number 1 in Drug Sales.NEWS2: UPDATE 2-U.S. FDA set to authorize Pfizer COVID-19 shot for ages 12-15 early next week - NYT.NEWS3: Vaccine Hesitancy Ticks Down — Here's What That Means For Covid Stocks.NEWS4: Brazil looks to new Pfizer contract to speed up vaccinations.NEWS5: Was The Smart Money Right About Pfizer Inc. (PFE)?.NEWS6: BioNTech Hits Record as Vaccine Success Spurs on Biotechs.NEWS7: A ‘one size fits all policy’ for reopening travel is very concerning: Doctor.NEWS8: Pfizer says it told India there no safety concern with its COVID-19 vaccine.NEWS9: Pfizer’s Earnings Are Tuesday. Here’s What to Expect..NEWS10: Why BioNTech Stock Is Jumping Today.NEWS11: Pfizer's COVID-19 Pill Could Be Here By Year-End: Investor Impact.NEWS12: With earnings on track for best growth in more than a decade, here come Uber, Lyft and the vaccine makers.NEWS13: Dow Jones Rallies 300 Points To Lead Stock Market; Is A New Closing High Next?.NEWS14: Pfizer Earnings: What to Look For From PFE.NEWS15: People should focus on wearing masks indoors 'where it matters the most': Doctor.NEWS16: COVID-19 latest: U.S. cases fall, EU looks to reopen, India cases on the rise.NEWS17: Pfizer's (PFE) Key Drugs Likely to Drive Its Q1 Earnings.NEWS18: Pfizer says it submitted application for COVID-19 vaccine to Indian regulators 'months ago'.NEWS19: Pfizer Gets White House Support for Exporting Vaccines.NEWS20: UPDATE 1-India's vaccinations plummet as coronavirus infections soar.NEWS21: Uber, Pfizer, ViacomCBS, General Motors, and Other Stocks to Watch This Week.NEWS22: Is a Beat in Store for BioNTech (BNTX) This Earnings Season?.NEWS23: 3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes.NEWS24: BioNTech Jumps on EU Drug Regulator's Review of Covid Vaccine for Kids.NEWS25: Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point?.NEWS26: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, GlaxoSmithKline, Novartis and Johnson & Johnson.NEWS27: The 2 Numbers I'll Be Looking for in Moderna's Earnings Report This Week.NEWS28: India's vaccinations plummet as coronavirus infections soar.NEWS29: Pfizer in talks with India over expedited approval for COVID-19 vaccine.
2021-05-04: NEWS1: Pfizer: Anticipated Growth at a Fair Value.NEWS2: UPDATE 1-People aged over 50 in Britain to be offered 3rd COVID vaccine shot in autumn -The Times.NEWS3: Vaccine Sales Lift Pfizer’s Quarterly Results.NEWS4: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS5: India Deaths May Double; Seychelles Cases Surge: Virus Update.NEWS6: What happened in the stock market today? Tech sees worst day since March, Dow ekes out gain.NEWS7: Pfizer Stock Eyes Breakout On Call For $26 Billion In Covid Vaccine Sales.NEWS8: CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline.NEWS9: Dow manages to end up, but tech shares see worst one day fall since March.NEWS10: Pfizer Covid Vaccine Set to Become Highest-Selling Medication Ever.NEWS11: Pfizer in talks with India for COVID-19 vaccine.NEWS12: CVS Says Covid-19 Vaccinations Slow as U.S. Rollout Runs Into Hesitancy.NEWS13: How businesses are tracking their employee's vaccination status and well-being amid COVID-19 recovery.NEWS14: Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments.NEWS15: Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments.NEWS16: Pfizer CEO: 'We do think our stock is undervalued'.NEWS17: 'We’re entering the harder phase' of coronavirus vaccination.NEWS18: Biden aims to have 70% of U.S. adults receive first vaccine shot by July 4th.NEWS19: India’s COVID-19 case tally tops 20 million after nearly doubling in three months.NEWS20: Dow slides, Nasdaq tumbles 2.6% as fears of Fed tapering put investors on edge.NEWS21: Returning to normal ‘doesn’t have to be the goal’ amid COVID-19 recovery: Doctor.NEWS22: Pfizer Sees $26 Billion From Covid Shot, Big Potential Ahead.NEWS23: CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline.NEWS24: Pfizer's BCMA/CD3 Bispecific Candidate Study Derailed Amid Safety Woes.NEWS25: S&P 500 Falls After Yellen Triggers Rate Hike Jitters.NEWS26: Stock Market Today With Jim Cramer: Why It's Time to Buy Pfizer Stock.NEWS27: Stocks End Mixed as Tech Tumbles and Yellen Raises Rate Fears.NEWS28: Pfizer (PFE) Q1 Earnings Beat, COVID-19 Vaccine Boosts Sales.NEWS29: Why BioNTech Stock Is Sinking Today.NEWS30: Pfizer’s Covid-19 Vaccine Could Be Approved for 12- to 15-Year-Olds By Next Week.NEWS31: Pfizer Reports Better-Than-Expected 1Q Results, Lifts COVID-19 Vaccine Sales Outlook.NEWS32: Pfizer Knocks It Out of the Park With Its Q1 Results.NEWS33: S&P 500 Slips on Tech Wreck as Yellen Stokes Inflation Jitters.NEWS34: India’s COVID-19 case tally tops 20 million after nearly doubling in three months.NEWS35: Dow down 280 points, with tech shares under heavy pressure.NEWS36: Pfizer, UnderArmour Beat; Trade Deficit at All-Time Low.NEWS37: Pfizer’s Vaccine Drove a Big Earnings Beat. What It Means for the Stock..NEWS38: Nasdaq Sinks as Tech Tumbles and Yellen Raises Rates Fears.NEWS39: Pfizer Posts Strong Earnings and Boosts Its Covid-19 Vaccine Sales Forecast. What You Need to Know..NEWS40: U.S. stocks dip in early trade, with tech shares under pressure.NEWS41: Pfizer posts earnings beat driven by COVID-19 revenue.NEWS42: Pfizer Is Gaining, CVS Is Jumping, and the Stock Market Is Slipping.NEWS43: Nasdaq Sinks 2.6% on Rotation Out of Tech, Yellen's Rates Comments.NEWS44: Pfizer sees robust COVID-19 vaccine demand for years, $26 billion in 2021 sales.NEWS45: Pfizer Earnings: What Happened with PFE.NEWS46: The Stock Market Is Slipping. Why Strong Earnings Aren’t Enough..NEWS47: Pfizer Beats Q1 Wall Street Estimates; Sees COVID-19 Vaccine Sales Of $26B In FY21.NEWS48: Zacks Industry Outlook Highlights: Johnson & Johnson, AstraZeneca and Pfizer.NEWS49: Pfizer (PFE) Q1 Earnings and Revenues Surpass Estimates.NEWS50: Pfizer Earnings Top, Guidance Raised On Coronavirus Vaccine; Stock Rises In Buy Zone.NEWS51: Dow set for muted action Tuesday as investors await Yellen remarks, parse earnings from CVS, Pfizer.NEWS52: Pfizer Inc. to Host Earnings Call.NEWS53: Nasdaq Sinks 2.5% on Rotation Out of Tech, Yellen's Rates Comments.NEWS54: Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%.NEWS55: Pfizer bets on COVID-19 vaccine demand for years, sees sales of $26 billion in 2021.NEWS56: UPDATE 5-Pfizer bets on COVID-19 vaccine demand for years, sees sales of $26 bln in 2021.NEWS57: PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS.NEWS58: Coronavirus tally: Global cases of COVID-19 top 153.5 million and India's death toll above 200,000.NEWS59: Travel stocks rally as EU prepares to open borders to vaccinated holidaymakers.NEWS60: Nasdaq Sinks as Investors Rotate Out of Tech Sector and Growth Shares.NEWS61: Vaxart Jumps on Positive Phase 1 Data for Oral COVID Vaccine.NEWS62: Premarket Movers Tuesday - Pfizer, CVS Health, Precipio.NEWS63: Pfizer Gains as FDA Set to Approve Vaccine for Early Teens.NEWS64: Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?.NEWS65: UPDATE 1-South Africa allocates an extra $276 mln to fight COVID-19.NEWS66: Pfizer Beats Earnings Forecast, Sees $26 Billion In COVID Vaccine Sales.NEWS67: Reopening Trades, CO2 Record, Pfizer, Aramco Earnings - What's Moving Markets.NEWS68: Astellas' XTANDI™ (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS69: Gates Divorce, Ethereum and Pfizer: 5 Things You Must Know Tuesday.NEWS70: Pfizer generates $3.5bn from Covid vaccine sales in the first quarter.NEWS71: US set to approve Pfizer Covid vaccine for 12- to 15-year-olds.NEWS72: BioNTech/Pfizer Covid vaccine to be approved for 12 to 15-year-olds.NEWS73: Pfizer COVID-19 vaccine expected to get FDA approval for kids 12-15 this week.
2021-05-05: NEWS1: Inside India's Serum Institute: The vaccine manufacturer at the heart of the world's COVID vaccine supply.NEWS2: U.S. Backs Waiver of Intellectual Property Protection for Covid-19 Vaccines.NEWS3: President Biden to back waiving IP protections for COVID vaccines.NEWS4: US talk of waiving vaccine patents is merely symbolic: Experts.NEWS5: Moderna Booster Effective; Canada May Mix Shots: Virus Update.NEWS6: Moderna releases new information on booster shots.NEWS7: White House supports waiving IP protections for COVID vaccines.NEWS8: Biden administration backs waiving IP protections for COVID vaccines.NEWS9: Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters.NEWS10: Global COVID-19 caseload at pandemic high for second straight week, says WHO.NEWS11: Pfizer's Hospira To Call Back Hospital Anesthetics Due To Mislabeling.NEWS12: Former Acting CDC Director on why it's 'really important' to pay attention to COVID-19 variants.NEWS13: Why BioNTech Stock Is Jumping Again Today.NEWS14: COVID SCIENCE-Sperm not impacted by Pfizer/BioNTech vaccine; neuropsychiatric symptoms persist in COVID-19 survivors.NEWS15: Pfizer Will Meet Growth Goals Even Without Vaccine Sales, CFO Says.NEWS16: Has Pfizer (PFE) Outpaced Other Medical Stocks This Year?.NEWS17: Investing in the Covid-19 vaccine companies? Here’s the great divide in the group.NEWS18: Global cases of COVID-19 stayed at highest levels since start of the pandemic in latest week, says WHO.NEWS19: Global cases of COVID-10 stayed at highest levels since start of the pandemic in latest week, says WHO.NEWS20: Canada authorizes Pfizer's COVID-19 vaccine for kids between the ages of 12 and 15 years old.NEWS21: CORRECTED-UPDATE 3-Canada allows Pfizer COVID-19 vaccine for children aged 12-15.NEWS22: Moderna Reports Earnings on Thursday. Here’s What to Expect..NEWS23: UPDATE 1-U.S. FDA expected to authorize Pfizer vaccine for 12-15-year-olds soon.NEWS24: Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study?.NEWS25: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS26: Can This News Push Ocugen Ahead of Pfizer and Moderna?.NEWS27: S.Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot.NEWS28: Pfizer (PFE) Q1 2021 Earnings Call Transcript.NEWS29: The Top 10 Dividend Stocks to Buy in 2021.NEWS30: Canada approves first coronavirus vaccine for under-16s.

Answer: Decrease